Get the Stockscreener App
1.13
3.42%
-0.04
Iridex Corp stock is traded at $1.13, with a volume of 63,002.
It is down -3.42% in the last 24 hours and up +11.33% over the past month.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
See More
Previous Close:
$1.17
Open:
$1.17
24h Volume:
63,002
Relative Volume:
0.29
Market Cap:
$19.67M
Revenue:
$52.58M
Net Income/Loss:
$-3.28M
P/E Ratio:
-5.864
EPS:
-0.1927
Net Cash Flow:
$-2.53M
1W Performance:
+0.89%
1M Performance:
+11.33%
6M Performance:
+16.49%
1Y Performance:
+15.74%
1-Day Range:
$1.13
$1.185
1-Week Range:
$1.11
$1.195
52-Week Range:
$0.8688
$1.6481
Iridex Corp Stock (IRIX) Company Profile
Name
Iridex Corp
Sector
Industry
Phone
(650) 940-4700
Address
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Compare IRIX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.13 | 19.67M | 52.58M | -3.28M | -2.53M | -0.1927 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-17 | Resumed | ROTH Capital | Buy |
| Dec-21-16 | Initiated | ROTH Capital | Buy |
| Jan-26-16 | Initiated | Singular Research | Buy |
| Jan-03-07 | Initiated | First Albany | Buy |
Iridex Corp Stock (IRIX) Latest News
IRIDEX (IRIX) adjourns 2026 shareholder meeting, sets July 10 reconvene date - Stock Titan
IRIDEX Corp (IRIX) Institutional Confidence - TradingKey
IRIDEX Corp (IRIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRIDEX Corp (IRIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IRIDEX Corp (IRIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IRIDEX Corp (IRIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IRIDEX Corp (IRIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IRIDEX (IRIX) CFO has 2,691 shares withheld to pay taxes - Stock Titan
IRIDEX (IRIX) CEO surrenders 3,990 shares to cover tax obligations - Stock Titan
IRIDEX Corp (IRIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Insider Buying: Romeo Dizon Acquires Additional Shares of IRIDEX Corp (IRIX) - GuruFocus
Iridex CFO Romeo Dizon buys $1,110 in company stock - Investing.com UK
Iridex CFO Romeo Dizon buys $1,110 in company stock By Investing.com - Investing.com India
IRIDEX (IRIX) CFO Romeo Dizon adds 975 common shares in open-market buy - Stock Titan
IRIX News | IRIDEX CORP (NASDAQ:IRIX) - ChartMill
Iridex CFO Romeo Dizon buys $1,909 in company stock By Investing.com - Investing.com Australia
Iridex CFO Romeo Dizon buys $1,909 in company stock - Investing.com
IRIDEX (IRIX) CFO Romeo Dizon adds 1,675 shares in open-market stock purchase - Stock Titan
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference - The Manila Times
Iridex CFO Romeo Dizon buys $2,688 in company stock By Investing.com - Investing.com Australia
Iridex CFO Romeo Dizon buys $2,688 in company stock - Investing.com
IRIDEX (IRIX) CFO Romeo Dizon adds 2,400 shares in open-market buy - Stock Titan
Iridex CFO Dizon purchases $2,899 of common stock By Investing.com - Investing.com India
Iridex CFO Dizon purchases $2,899 of common stock - Investing.com UK
IRIDEX Corp (IRIX) CFO adds 2,521 shares in open-market stock purchase - Stock Titan
IRIDEX Corp stock (US4627191006): Laser eye-care specialist after recent earnings update - AD HOC NEWS
Iridex CFO Romeo Dizon buys $2,808 in company stock By Investing.com - Investing.com Nigeria
Iridex CFO Romeo Dizon buys $2,808 in company stock - Investing.com
CFO of IRIDEX (NASDAQ: IRIX) purchases 2,400 company shares - Stock Titan
Iridex CFO Romeo Dizon buys $5,004 in company stock By Investing.com - Investing.com Australia
IRIDEX (IRIX) CEO Patrick Mercer delivers shares to cover tax obligations - Stock Titan
Iridex CFO Romeo Dizon buys $5,004 in company stock - Investing.com
IRIDEX Corp (IRIX) CFO adds 5,004 common shares in open-market buy - Stock Titan
IRIDEX Trades Around $1 Following Holiday, Eye-Care Firm Faces Next Challenges - Bez Kabli
IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth - Yahoo Finance
IRIDEX Corporation (IRIX) Q1 2026 Earnings Surge: EPS $-0.03 vs $-0.07 ForecastGross Profit Margin - Newser
Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Iridex (IRIX) - The Globe and Mail
IRIDEX Corporation (NASDAQ:IRIX) Q1 2026 Earnings Call Transcript - Insider Monkey
IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Growth Initiatives - GuruFocus
IRIDEX Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Iridex Beats Profit Forecasts on Cost Cuts Amidst Revenue Dip - BriefGlance
Earnings call transcript: IRIDEX Q1 2026 posts EPS beat despite revenue miss - Investing.com
Iridex Corp Stock (IRIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):